Lauren Riker served as the Interim Chief Financial Officer at Pacira BioSciences Inc., a specialty pharmaceutical company focused on developing, commercializing, and manufacturing innovative products that improve patient care and health economics. During her tenure, Riker played a crucial role in overseeing the company's financial operations, ensuring fiscal stability and strategic growth. Her leadership was instrumental in guiding Pacira BioSciences through a period of transition, maintaining the company's commitment to delivering non-opioid pain management solutions. Prior to her role at Pacira BioSciences, Riker built an extensive career in finance and healthcare, working with various organizations to enhance their financial strategies and operational efficiencies. She has a proven track record of successfully navigating complex financial landscapes and implementing robust financial systems that support sustainable growth. Riker's expertise in financial planning and analysis, coupled with her deep understanding of the healthcare industry, made her a valuable asset to Pacira BioSciences during her time as Interim CFO. Riker's professional achievements extend beyond her role at Pacira BioSciences. She has been recognized for her contributions to the field of finance within the pharmaceutical sector, often speaking at industry conferences and contributing to thought leadership discussions. Her strategic vision and dedication to excellence have solidified her reputation as a respected leader in the industry. As Interim CFO, Riker not only managed the financial aspects of the company but also contributed to its overall mission of advancing patient care through innovative medical solutions.